<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04638894</url>
  </required_header>
  <id_info>
    <org_study_id>S63875</org_study_id>
    <nct_id>NCT04638894</nct_id>
  </id_info>
  <brief_title>Variability in ASD Value</brief_title>
  <acronym>VIAV</acronym>
  <official_title>Are Patient Characteristics and Treatment Characteristics Related to the Value of the Adult Spinal Deformity (ASD) Care Pathway in University Hospitals Leuven?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will examine if variability in created value (outcome/costs) over the care cycle&#xD;
      for ASD patients can be explained by patient and treatment characteristics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Generic Value</measure>
    <time_frame>2 years</time_frame>
    <description>Generic outcome, measured via the EuroQol 5D (EQ-5D), divided by costs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease specific value: Scoliosis Research Society Outcomes Questionnaire (SRS-22)</measure>
    <time_frame>2 years</time_frame>
    <description>Disease-specific value, measured via the Scoliosis Research Society Outcomes Questionnaire (SRS-22), divided by costs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease specific value: Oswestry Low Back Pain Disability Questionnaire (ODI)</measure>
    <time_frame>2 years</time_frame>
    <description>Disease-specific value, measured via the Oswestry Low Back Pain Disability Questionnaire (ODI), divided by costs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease specific value: Core Outcome Measures Index (COMI)</measure>
    <time_frame>2 years</time_frame>
    <description>Disease-specific value, measured via the Core Outcome Measures Index (COMI), divided by costs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Workstatus</measure>
    <time_frame>2 years</time_frame>
    <description>Workstatus, following the International Consortium for Health Outcomes Measurement (ICHOM) standard low back pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to work</measure>
    <time_frame>2 years</time_frame>
    <description>Return to work, following the International Consortium for Health Outcomes Measurement (ICHOM) standard low back pain</description>
  </secondary_outcome>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Hospital Costs</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical treatment of patients with adult spinal deformity</intervention_name>
    <description>Including all surgical interventions for patients with adult spinal deformity.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population of patients, diagnosed with ASD, with an index surgery between 15 march 2020 and&#xD;
        15 march 2022 at University Hospitals Leuven.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult Spinal Deformity patients&#xD;
&#xD;
          -  Index Surgery from 15/03/2020 and 15/03/2022&#xD;
&#xD;
          -  Age of 18 years old or older at the moment of the index surgery&#xD;
&#xD;
          -  Patients treated in University Hospitals Leuven&#xD;
&#xD;
          -  Patient has full understanding and is willing to participate (Informed consent)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Patients younger than 18 years old at the moment of index surgery&#xD;
&#xD;
               -  Patients with an index surgery before 15/03/2020&#xD;
&#xD;
               -  Patients treated in other centers outside of University Hospitals Leuven&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lieven Moke</last_name>
    <role>Principal Investigator</role>
    <affiliation>prof. dr.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristel Van de loock</last_name>
    <phone>003216341266</phone>
    <email>orthopedie.research@uz.kuleuven.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

